Head and Neck Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer
Conditions: Head and Neck Cancer Sponsors: IRCCS San Raffaele Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
Conditions: Cancer; Breast Cancer; Brain Cancer; Central Nervous System Cancer; Colorectal Cancer; Esophageal Cancer; Gynecologic Cancer; Head and Neck Cancer; Gastrointestinal Cancer; Genitourinary Cancer; Melanoma; Blood Cancer; Lung Cancer; Acceptance and Commitment Therapy; Mind-Body Therapies; Psychosocial Intervention Interventions: Other: Mind Over Matter (MOM) Sponsors: Inova Health Care Services; Howard University; University of Louisville; University of Houston; Massey Cancer Center; Tigerlily Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A " Window of Opportunity " Pilot Study.
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Methylnaltrexone Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Submental Flap for the Reconstruction of Hypopharyngectomy
Conditions: Head and Neck Cancers - Hypopharyngeal Interventions: Other: Surgical reconstruction Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma
Conditions: Stage II Squamous Cell Carcinoma of the Head and Neck; Stage III Squamous Cell Carcinoma of the Head and Neck; Stage IV Squamous Cell Carcinoma of the Head and Neck Interventions: Drug: N-803; Drug: pembrolizumab; Biological: PD-L1 t-haNK cells Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Pilot Study of the eHealth Application " Cancer Patients Better Life Experience " (CAPABLE) - Italy
Conditions: Renal Cell Carcinoma Metastatic; Breast Cancer; Head and Neck Cancer; Thyroid Cancer; Ovary Cancer; Lung Cancer; Stomach Cancer Interventions: Device: CAPABLE cohort Sponsors: Istituti Clinici Scientifici Maugeri SpA; University of Pavia; Policlinico di Bari Ospedale Giovanni Paolo XXIII; Biomeris srl; The Netherlands Cancer Institute NKI; University of Haifa; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); IBM Research; Bitsens JSC; Pozna ń University of Technology; Deontics LTD; Associazione Italiana Malati di Cancro AIMAC; Universidad Politécnica de Madrid. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials

Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal
Conditions: Head and Neck Cancer Sponsors: Tribhuvan University, Nepal Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Conditions: Non Small Cell Lung Cancer; Triple Negative Breast Cancer; Hodgkin Lymphoma; Head and Neck Squamous Cell Carcinoma; Malignant Melanoma Interventions: Drug: CTX-8371 Sponsors: Compass Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials

Manual Therapy for Oral Health on Head and Neck Cancer Survivors
Conditions: Head and Neck Cancer; Trismus; Dysfunction Interventions: Other: Manual Therapy; Other: Control motor exercises Sponsors: Universidad de La Frontera Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
Conditions: Advanced Solid Tumor; Metastatic Colorectal Carcinoma; Head and Neck Squamous Cell Carcinoma; Non-small Cell Lung Cancer; Pancreatic Ductal Adenocarcinoma Interventions: Drug: FPI-2053; Drug: [111In]-FPI-2107; Drug: [225Ac]-FPI-2068 Sponsors: Fusion Pharmaceuticals Inc.; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials

A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer
Conditions: Head and Neck Cancer Interventions: Drug: Xevinapan; Drug: Cisplatin; Radiation: External beam Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials

Anterior Thoracic Perforating Artery (PATA); Systematization and Applications in Reconstructive Surgery of the Head and Neck
Conditions: Upper Aero-intestinal Tract Cancer; Supraclavicular Flap; Anterior Thoracic Perforator Artery Interventions: Procedure: Doppler ultrasound Sponsors: Ramsay G énérale de Santé; mermoz hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
Conditions: Squamous Cell Carcinoma of Head and Neck; Hypopharyngeal Squamous Cell Carcinoma; Laryngeal Squamous Cell Carcinoma Stage III; Laryngeal Squamous Cell Carcinoma Stage IV; Squamous Cell Carcinoma of Larynx; Squamous Cell Carcinoma of the Larynx; Squamous Cell Carcinoma of the Larynx Stage III; Squamous Cell Carcinoma of the Larynx Stage IV; Laryngeal Squamous Cell Carcinoma; Laryngectomy; Status; Laryngeal Cancer; Laryngeal Neoplasms Interventions: Biological: KEYTRUDA ® Sponsors: University of Leipzig; University of G öttingen; University of Jena; University of Cologne; University of Ulm; University of Regens...
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials

Pilot Trial of MR-guided Adaptive Radiotherapy Boost for HNSCC
Conditions: Squamous Cell Carcinoma; Head and Neck Cancer Interventions: Radiation: Intensity-modulated radiotherapy; Other: Magnetic Resonance Guidance Sponsors: H. Lee Moffitt Cancer Center and Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials

Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers
Conditions: Head and Neck Cancer Interventions: Genetic: PCR - Immunohistochemistry - Immunolabelling Sponsors: GCS Ramsay Sant é pour l ' Enseignement et la Recherche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials